Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApq Global Regulatory News (APQ)

  • There is currently no data for APQ

Refinancing Update & Proposed CULS Holder Payment

24 Sep 2024 13:00

RNS Number : 4648F
APQ Global Limited
24 September 2024
 

APQ Global Limited

 

("APQ Global" or the "Company")

 

Refinancing Update & Proposed Initial Payment to CULS Holders

 

Further to the Company's 6th September 2024 announcement in connection with the publication of proposals and the convening of a meeting of CULS Holders for the extension of the settlement date for the CULS, the Company provides the following update.

 

In response to feedback from CULS Holders on the proposals APQ Global provides some additional information on Delphos, the financial advisory business for emerging markets private credit that is wholly owned by the Company, an overview on the Company's efforts to date to refinance the CULS, and a liquidity update and proposed amendment to the terms of the proposals to CULS holders which, subject to CULS Holders approving the proposals, would involve an initial payment to CULS Holders on the CULS maturity date.

 

Delphos

 

Since the Company acquired Delphos in 2022, it has invested $12.45m in cash contributions to Delphos entities. The table below sets out a schedule of these cash contributions per quarter:

 

USD ('000)

2022 Q2

2022 Q3

2022 Q4

2023 Q1

2023 Q2

2023 Q3

2023 Q4

2024 Q1

2024 Q2

2024 Q3

Total

Working Capital

125

290

1,768

985

1,605

2,262

- 254

- 1,759

2,084

826

7,930

Equity

-

-

-

350

150

329

3,091

250

250

100

4,520

Total Cash Contributions

125

290

1,768

1,335

1,755

2,591

2,837

- 1,509

2,334

926

12,450

Source: Management

 

As stated in the 6th September announcement, Delphos is currently executing around 40 transactions in around 20 countries and the portfolio is diversified across geographies (Africa, Central Asia, Middle East, Latin America and South-East Asia) and sectors (infrastructure, renewables, financial services and funds).

 

Overview of CULS refinancing discussions

 

Over the past two months the Company has engaged with over 10 counterparties for refinancing the CULS, including:

· A bank with a focus on emerging markets. An NDA has been signed and information is being exchanged.

· A private markets fund based in Latin America with a specific strategy to develop a global origination platform. An NDA has been signed and information is being exchanged.

· An EM private markets fund backed by a large EM bank.

· Boston-based emerging market funds looking to grow in EM private markets.

· Various other EM-focused funds in the US and Europe.

 

Pending the publication of its FY23 accounts and the resumption of trading in the Company's ordinary shares and CULS, the Company intends to commence negotiating formal terms with counterparties expediently with the aim of securing a financing facility for the Company by FY24 year-end.

 

Liquidity Update and Proposed Initial Payment to CULS Holders

 

The Company confirms that its cash balance currently stands at $9.6m. The Company is required to post collateral of $3.0m towards its GBPUSD currency hedge of the CULS liability. Additionally, the Company believes that it is prudent to reserve $4.0m as a working capital buffer.

 

The Company is committed to repaying as much capital as possible to CULS Holders as quickly as possible over the next six months as income from Delphos' operations and the proposed refinancing is received. To ensure full repayment of the premium redemption and increased coupon, it is imperative that the Company retains its currency hedge of the CULS liability and retains sufficient working capital to monetize its expected cashflows from operations.

 

In response to feedback from CULS Holders, the Company also proposes that, if the proposals set out in the Circular are approved at the meeting of the CULS Holders on 30th September 2024, it will pay, on the Maturity Date of 30th September 2024, an amount equal to $2.7m (£2.0m), representing approximately 6.76 per cent. of the aggregate redemption proceeds of the CULS at the Maturity Date (the "Initial Payment"). The Initial Payment will be made to the Trustee for onward payment to CULS Holders. If the Resolution to be proposed at the Meeting of CULS Holders is passed, the Trust Deed will be amended as set out in the Circular. The amendments would take effect from completion of the Initial Payment and would therefore be in respect of the reduced outstanding principal amount of CULS.

 

Terms used and not defined in this announcement shall have the meanings given to them in the Circular published on 6th September 2024.

 

- End -

 

 

For further enquiries, please contact:

 

APQ Global Limited Bart Turtelboom

020 3478 9708

 

Singer Capital Markets - Nominated Adviser and Broker James Maxwell/Sam Greatrex

020 7496 3000

Suntera - TISE sponsor Claire Torode

01481 737 277

Investor Relations

IR@APQGlobal.com

 

 

Notes to Editors

 

APQ Global Limited

 

APQ Global (ticker: APQ LN) is an investment company incorporated in Guernsey. The Company focuses its investment activities globally (in Asia, Latin America, Eastern Europe, the Middle East, Africa and the Channel Islands, particularly). The objective of the Company is to steadily grow its earnings to seek to deliver attractive returns and capital growth through a combination of building growing businesses as well as earning revenue from income generating operating activities in capital markets1. APQ Global run a well-diversified and liquid portfolio, take strategic stakes in selected businesses and plan to take operational control of companies through the acquisition of minority and majority stakes in companies with a focus on emerging markets. For more information, please visit apqglobal.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDZZGZLMDLGDZM
Date   Source Headline
15th Nov 20177:00 amRNSBook Value Report
31st Oct 20177:00 amRNSNew appointment to Advisory Council
19th Oct 20177:00 amRNSOutlook
19th Oct 20177:00 amRNSDividend Declaration
19th Oct 20177:00 amRNSQuarterly Update
16th Oct 20177:00 amRNSBook Value Report
12th Oct 20177:00 amRNSNew appointment to Advisory Council
9th Oct 20177:00 amRNSAdvisory Council further strengthened
26th Sep 201711:23 amRNSInterim Results for the Period to 30 June 2017
15th Sep 20177:00 amRNSBook Value Report
6th Sep 20175:00 pmRNSTrading in CULS
4th Sep 20172:00 pmRNSResults of Extraordinary General Meeting
16th Aug 20177:00 amRNS2017 Mid-Year Review
15th Aug 20177:05 amRNSSuccessful Fundraising
15th Aug 20177:00 amRNSBook Value Report
8th Aug 20173:00 pmRNSResult of AGM
8th Aug 20177:46 amRNSAppointment to the International Advisory Council
17th Jul 20177:00 amRNSQuarterly Update
17th Jul 20177:00 amRNSDividend Declaration
17th Jul 20177:00 amRNSBook Value Report
17th Jul 20177:00 amRNSPublication of Annual Report and Notice of AGM
12th Jul 20177:00 amRNSAppointments to the International Advisory Council
29th Jun 20175:56 pmRNSReport and Accounts
15th Jun 20177:00 amRNSPotential Capital Raise
15th Jun 20177:00 amRNSBook Value Report
13th Jun 20177:00 amRNSPotential Capital Raise
15th May 20177:00 amRNSBook Value Report
20th Apr 20174:45 pmRNSDividend Declaration
20th Apr 20174:45 pmRNSQuarterly Update
18th Apr 20177:00 amRNSBook Value Report
15th Mar 20177:00 amRNSBook Value Report
15th Feb 20177:00 amRNSBook Value Report
10th Feb 20177:00 amRNSOutlook
16th Jan 20177:00 amRNSQuarterly Update
16th Jan 20177:00 amRNSDividend Declaration
16th Jan 20177:00 amRNSBook value report
15th Dec 20167:00 amRNSBook value report
8th Dec 20165:30 pmRNSDirector/PDMR Shareholding
15th Nov 20167:00 amRNSBook value announcement
28th Oct 20167:00 amRNSQuarterly Update
17th Oct 20167:00 amRNSBook value report
19th Sep 201611:01 amRNSTR-1: Notification of Major Interest in Shares
26th Aug 20167:00 amRNSAdmission to trading on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.